| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Murphy Matthew B. is a General Counsel at Nautilus Biotechnology, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $199K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | NAUT Nautilus Biotechnology, Inc. | General Counsel | Buy | 20,000 | $0.64 | $12,858.00 | +36.9% | +219.1% | - | |
| Aug 15, 2022 | NAUT Nautilus Biotechnology, Inc. | General Counsel | Buy | 10,000 | $2.84 | $28,432.50 | +11.0% | -29.8% | +9.6% | |
| Aug 13, 2021 | NAUT Nautilus Biotechnology, Inc. | General Counsel | Buy | 5,000 | $7.56 | $37,806.50 | +17.2% | -31.9% | -62.2% |